FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. Ecstasy (Drug), Post-Traumatic Stress Disorder, Psychedelic and Hallucinogenic Drugs, Drug Abuse and Traffic, Veterans, Mental Health and Disorders, Regulation and Deregulation of Industry, Therapy and Rehabilitation, Clinical Trials, Research, Alternative and Complementary Medicine, Food and Drug Administration, Lykos Therapeutics The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. NYT > Business